Next-generation isoform-selective fibroblast growth factor receptor inhibitors
Trends in Pharmacological Sciences · 2025-11 · 46 (11) · 1091-1104
DOI: 10.1016/j.tips.2025.09.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2025-11. Verfasst von Lingfeng Chen. Beteiligte Einrichtung: Chemical Biology Research Center, School of Pharmacy, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China; Zhejiang Provincial Key Laboratory …. Hauptthemen laut MEDLINE: Receptors, Fibroblast Growth Factor, Protein Kinase Inhibitors, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical Biology Research Center, School of Pharmacy, Hangzhou Medical College, Hangzhou 310014, Zhejiang, China; Zhejiang Provincial Key Laboratory of Drug Discovery and Safety Evaluation for Inflammatory Chronic Disea…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Chen, L. (2025). Next-generation isoform-selective fibroblast growth factor receptor inhibitors. Trends in Pharmacological Sciences, 46(11), 1091-1104. https://doi.org/10.1016/j.tips.2025.09.004
Vancouver
Chen L. Next-generation isoform-selective fibroblast growth factor receptor inhibitors. Trends in Pharmacological Sciences. 2025;46(11):1091-1104. doi:10.1016/j.tips.2025.09.004
BibTeX
@article{Chen2025,
author = {Chen, Lingfeng},
title = {Next-generation isoform-selective fibroblast growth factor receptor inhibitors},
journal = {Trends in Pharmacological Sciences},
year = {2025},
volume = {46},
number = {11},
pages = {1091--1104},
doi = {10.1016/j.tips.2025.09.004}
}
EUVIMED